Axsome Therapeutics (AXSM) Net Margin Growth (3y) (2025 - 2026)

Axsome Therapeutics (AXSM) Net Margin Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Oculis Holding AG 66,861.65 Bn 66,861.36 Bn - -
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn - -
3 Akari Therapeutics 973.81 Bn 973.81 Bn - -
4 BeOne Medicines 471.51 Bn 466.72 Bn 1.35 Bn 9,283.00
5 Vertex Pharmaceuticals 121.94 Bn 114.70 Bn 2.59 Bn 506.00
6 Regeneron Pharmaceuticals 70.05 Bn 61.30 Bn 3.31 Bn -569.00
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.88 Bn 50.69 Bn 1.41 Bn 6,537.00
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn 7,218.00
10 Axsome Therapeutics 12.25 Bn 11.94 Bn 176.48 Mn -2,187.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,187.00
Dec 31, 2025 23,668.00
Sep 30, 2025 23,845.00
Jun 30, 2025 43,785.00